RESEARCH TRIANGLE PARK, NC – May 5, 2014 – Dignify Therapeutics, a drug development company focused on developing novel bladder and bowel drug therapies for patients with spinal conditions, today announced that it has become a member of the Blackstone Entrepreneurs Network (BEN). Blackstone Companies come from across the region and are selected through a multi-stage diligence process. Working closely with the areas entrepreneurial organizations and universities, the BEN scouts for startups and technologies with the highest growth potential and committed teams.
“We are very excited about, and appreciative of, the opportunity that the BEN offers Dignify. Our company certainly has the potential for significant growth given the unmet need in the therapeutic area we are focused on. Our very experienced and committed management team looks forward to achieving our goals with the support of the BEN,” said Benny Ward, Chief Executive Officer of Dignify Therapeutics.
About The Blackstone Entrepreneurs Network
Blackstone Entrepreneurs Network was launched in North Carolina in 2011 with a gift from The Blackstone Charitable Foundation. The Network’s mission is to help catalyze the regional development of the Triangle’s entrepreneurial ecosystem and thereby strengthen economic development in the area.
The Network harnessed the talent of a regional pool of veteran entrepreneurs, and in 2012 created a tightly connected team of Entrepreneurs-in-Residence (EIRs) to help identify marketable innovations out of area universities and regional startups with the greatest potential to become high-growth companies.
EIRs work one-on-one and as a team to mentor local entrepreneurs and help them achieve significant business milestones, make connections to their network of experts and funders, and provide access to the broader Blackstone Entrepreneurs Network. Network portfolio companies enjoy access to sector experts, venture coaches, angel investors, and administrative and marketing support provided by Network Fellows.
The Network supports its Partners (UNC-Chapel Hill, Duke University, NC State, NC Central University, CED) and the Triangle entrepreneurial community through sponsorship and participation in regional entrepreneurship events, providing Network expertise through panels and conferences, and maximizing Network impact through strategic partnerships and community outreach.
About Dignify Therapeutics LLC
Founded by a team of serial entrepreneurs who are internationally-recognized scientists and clinicians, Dignify Therapeutics’ mission is to provide safe and effective, practical and convenient, “on-demand” pharmaceutical agents to treat bladder and bowel voiding dysfunctions, using a “repositioning” strategy of drug discovery that the team has successfully implemented multiple times over the last 20 years in the fields of urology and gastroenterology. Funding to the Company has been provided by the North Carolina Biotechnology Center, an entity primarily funded by the State of North Carolina.
P.O. Box 13169 – 2 Davis Drive
Research Triangle Park, NC 27709